|
2025-04-04 |
2025-04-02 |
V
Vente
|
Tactic Pharma LLC
Chief Executive Officer
Administrateur exécutif
Actionnaire important
|
33 334
-3.9%
35,00
1 166 690 USD
|
33 334
-3.9%
|
35,00
|
1 166 690 USD
|
|
|
2024-10-30 |
2024-10-28 |
A
Achat
|
Radhakrishnan Karthik
Chief Financial Officer
Dirigeant
|
1 550
+inf%
16,25
25 188 USD
|
1 550
+inf%
|
16,25
|
25 188 USD
|
|
|
2024-06-21 |
2024-06-20 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
20 508
+12.4%
0,74
15 254 USD
|
20 508
+12.4%
|
0,74
|
15 254 USD
|
|
|
2024-06-21 |
2024-06-18 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+7.8%
0,86
10 320 USD
|
12 000
+7.8%
|
0,86
|
10 320 USD
|
|
|
2024-06-17 |
2024-06-17 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+8.5%
0,90
10 799 USD
|
12 000
+8.5%
|
0,90
|
10 799 USD
|
|
|
2024-06-17 |
2024-06-14 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+9.3%
0,93
11 176 USD
|
12 000
+9.3%
|
0,93
|
11 176 USD
|
|
|
2024-06-17 |
2024-06-13 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+10.2%
0,91
10 920 USD
|
12 000
+10.2%
|
0,91
|
10 920 USD
|
|
|
2024-06-05 |
2024-06-04 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+11.4%
0,78
9 360 USD
|
12 000
+11.4%
|
0,78
|
9 360 USD
|
|
|
2024-06-05 |
2024-06-03 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+12.8%
0,76
9 120 USD
|
12 000
+12.8%
|
0,76
|
9 120 USD
|
|
|
2024-05-31 |
2024-05-31 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+14.7%
0,64
7 732 USD
|
12 000
+14.7%
|
0,64
|
7 732 USD
|
|
|
2024-05-31 |
2024-05-30 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+17.2%
0,64
7 676 USD
|
12 000
+17.2%
|
0,64
|
7 676 USD
|
|
|
2024-05-31 |
2024-05-29 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
12 000
+20.8%
0,64
7 643 USD
|
12 000
+20.8%
|
0,64
|
7 643 USD
|
|
|
2022-11-16 |
2022-11-15 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
10 000
+70.2%
3,15
31 500 USD
|
10 000
+70.2%
|
3,15
|
31 500 USD
|
|
|
2022-11-16 |
2022-11-14 |
A
Achat
|
Cittadine Andrew
Chief Operating Officer
Dirigeant
|
6 053
+74.0%
3,00
18 159 USD
|
6 053
+74.0%
|
3,00
|
18 159 USD
|
|
|
2021-02-16 |
2021-02-11 |
VP
Vente planifiée
|
Tactic Pharma LLC
Chief Scientific Officer
Actionnaire important
|
11 929
-6.7%
16,90
201 600 USD
|
11 929
-6.7%
|
16,90
|
201 600 USD
|
|
|
2021-02-16 |
2021-02-11 |
VP
Vente planifiée
|
Tactic Pharma LLC
Chief Scientific Officer
Actionnaire important
|
16 384
-8.4%
16,44
269 353 USD
|
16 384
-8.4%
|
16,44
|
269 353 USD
|
|
|
2021-02-16 |
2021-02-11 |
VP
Vente planifiée
|
Tactic Pharma LLC
Chief Scientific Officer
Actionnaire important
|
29 996
-13.3%
15,12
453 540 USD
|
29 996
-13.3%
|
15,12
|
453 540 USD
|
|
|
2021-02-16 |
2021-02-11 |
VP
Vente planifiée
|
Tactic Pharma LLC
Chief Scientific Officer
Actionnaire important
|
24 224
-9.7%
14,09
341 316 USD
|
24 224
-9.7%
|
14,09
|
341 316 USD
|
|
|
2021-02-16 |
2021-02-11 |
VP
Vente planifiée
|
Tactic Pharma LLC
Chief Scientific Officer
Actionnaire important
|
42 467
-14.6%
13,30
564 811 USD
|
42 467
-14.6%
|
13,30
|
564 811 USD
|
|
|
2019-12-20 |
2019-12-18 |
A
Achat
|
Tsuchimoto Kim R
Chief Financial Officer
|
325
+inf%
8,00
2 600 USD
|
325
+inf%
|
8,00
|
2 600 USD
|
|
|
2019-12-20 |
2019-12-18 |
A
Achat
|
Tactic Pharma LLC
Chief Scientific Officer
|
125 000
+75.0%
8,00
1 000 000 USD
|
125 000
+75.0%
|
8,00
|
1 000 000 USD
|
|
|
2019-12-20 |
2019-12-18 |
A
Achat
|
Hendricks Diane
|
468 750
+inf%
8,00
3 750 000 USD
|
468 750
+inf%
|
8,00
|
3 750 000 USD
|
|
|
2019-12-20 |
2019-12-18 |
A
Achat
|
Leo Karl
|
314
+inf%
8,00
2 510 USD
|
314
+inf%
|
8,00
|
2 510 USD
|
|
|
2019-12-20 |
2019-12-18 |
A
Achat
|
Leo Karl
|
156 250
+inf%
8,00
1 250 000 USD
|
156 250
+inf%
|
8,00
|
1 250 000 USD
|
|
